Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 30, 2019
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
British Journal of Clinical Pharmacology
|
March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database
Patrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 21, 2021
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
World Journal of Urology
|
June 10, 2025
Comparative effectiveness of robot-assisted vs. open prostatectomy: a real-life nationwide study
Grégoire Robert, Patrick Blin, Franck Bladou, et al.
Pharmacoepidemiology and Drug Safety
|
March 26, 2024
Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database
Nicolas H Thurin, Angela Grelaud, Adeline Grolleau, et al.
British Journal of Clinical Pharmacology
|
November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 2018
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Pharmacoepidemiology and Drug Safety
|
November 9, 2022
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 23, 2026
Dual Antiplatelet Therapy beyond 1 Year after a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims Database
Patrick Blin, Nicolas Danchin, Jacques Benichou, et al.
Epidemiology (Cambridge, Mass.)
|
October 1, 2013
Relative risks from case-population data
Nicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 30, 2019
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
British Journal of Clinical Pharmacology
|
March 28, 2017
Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database
Patrick Blin, Caroline Dureau-Pournin, Régis Lassalle, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
December 21, 2021
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, et al.
World Journal of Urology
|
June 10, 2025
Comparative effectiveness of robot-assisted vs. open prostatectomy: a real-life nationwide study
Grégoire Robert, Patrick Blin, Franck Bladou, et al.
Pharmacoepidemiology and Drug Safety
|
March 26, 2024
Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database
Nicolas H Thurin, Angela Grelaud, Adeline Grolleau, et al.
British Journal of Clinical Pharmacology
|
November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 2018
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
Patrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Pharmacoepidemiology and Drug Safety
|
November 9, 2022
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting
Jeremy A Rassen, Patrick Blin, Sebastian Kloss, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 23, 2026
Dual Antiplatelet Therapy beyond 1 Year after a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims Database
Patrick Blin, Nicolas Danchin, Jacques Benichou, et al.
Epidemiology (Cambridge, Mass.)
|
October 1, 2013
Relative risks from case-population data
Nicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Page
of 10